Apixiban

Alternative Names: Eliquis

Apixaban (Eliquis) is a blood thinner taken twice a day to reduce the risk of stroke in patients with non-valvular atrial fibrillation. It works by blocking factor Xa in the clotting pathway to help prevent blood clots. Unlike warfarin, it does not require regular blood tests and has fewer food and drug interactions. The main risk is bleeding, but it is generally safe and widely used as a first-line option.

Treatment Type: Prescription Medication

Treatment Class: Factor Xa inhibitor

Treatment Modality: Oral

Apixiban

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Based on the review by Dr. Curbside, Apixaban appears to be an effective treatment for Atrial Fibrillation. It provides strong stroke prevention comparable to other direct oral anticoagulants (DOACs), while notably demonstrating a lower risk of major bleeding complications. This makes Apixaban a preferred and safe first-line option for long-term anticoagulation in patients with Atrial Fibrillation.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
3.0
1 = Very Expensive 5 = Very Affordable

3.0

Moderate Cost
Relief Speed
4.0
1 = No Relief 5 = Immediate Relief

4.0

Fast Relief
Side Effects
3.0
1 = Intolerable Effect 5 = No Effect

3.0

Moderate Effect
Treatment Line
5.0
1 = Third-line or more 5 = First-line

5.0

First-line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews
5
100%
4
0%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review by Dr. Curbside, Apixaban appears to be an effective treatment for Atrial Fibrillation. It provides strong stroke prevention comparable to other direct oral anticoagulants (DOACs), while notably demonstrating a lower risk of major bleeding complications. This makes Apixaban a preferred and safe first-line option for long-term anticoagulation in patients with Atrial Fibrillation.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
2 months ago
Apixaban is commonly used as a first-line anticoagulant for atrial fibrillation to reduce the risk of stroke. Among the factor Xa inhibitors, it’s often favored because studies suggest lower rates of major bleeding, particularly gastrointestinal bleeding, compared with some alternatives like Rivaroxaban. It’s also generally well tolerated and effective, which makes it a common go-to option when starting anticoagulation for non-valvular atrial fibrillation. For many patients, it strikes a good balance between strong stroke prevention and a relatively favorable bleeding risk profile compared with other medications in the same class.
#ModerateCost #CoveredByInsurance #FastRelief #ModerateEffect #First-line #Maintenance #Preventative
View Professional Disclosures

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All